Serum levels of VCAM‐1 are associated with survival in patients treated with nivolumab for NSCLC von Carbone, Federico, Ministrini, Stefano, Bonaventura, Aldo, Vecchié, Alessandra, Minetti, Silvia, Bardi, Nicholas, Elia, Edoardo, Ansaldo, Anna Maria, Ferrara, Daniele, Rijavec, Erika, Dal Bello, Maria Giovanna, Biello, Federico, Rossi, Giovanni, Tagliamento, Marco, Alama, Angela, Coco, Simona, Spallarossa, Paolo, Grossi, Francesco, Genova, Carlo, Montecucco, Fabrizio

Volltext

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study von Bonaventura, Aldo, Grossi, Francesco, Carbone, Federico, Vecchié, Alessandra, Minetti, Silvia, Bardi, Nicholas, Elia, Edoardo, Ansaldo, Anna Maria, Ferrara, Daniele, Rijavec, Erika, Dal Bello, Maria Giovanna, Rossi, Giovanni, Biello, Federica, Tagliamento, Marco, Alama, Angela, Coco, Simona, Spallarossa, Paolo, Dallegri, Franco, Genova, Carlo, Montecucco, Fabrizio

Volltext

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer von Carbone, Federico, Grossi, Francesco, Bonaventura, Aldo, Vecchié, Alessandra, Minetti, Silvia, Bardi, Nicholas, Elia, Edoardo, Ansaldo, Anna Maria, Ferrara, Daniele, Rijavec, Erika, Dal Bello, Maria Giovanna, Biello, Federica, Rossi, Giovanni, Tagliamento, Marco, Alama, Angela, Coco, Simona, Spallarossa, Paolo, Dallegri, Franco, Genova, Carlo, Montecucco, Fabrizio

Volltext